| 000 | 01468 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513064636.0 | ||
| 264 | 0 | _c19940701 | |
| 008 | 199407s 0 0 eng d | ||
| 022 | _a0039-2499 | ||
| 024 | 7 |
_a10.1161/01.str.25.6.1241 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHasegawa, Y | |
| 245 | 0 | 0 |
_aThe competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke. _h[electronic resource] |
| 260 |
_bStroke _cJun 1994 |
||
| 300 |
_a1241-4; discussion 1245-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xphysiology |
| 650 | 0 | 4 |
_aBody Temperature _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCarbon Dioxide _xblood |
| 650 | 0 | 4 | _aCerebral Arteries |
| 650 | 0 | 4 |
_aCerebral Infarction _xblood |
| 650 | 0 | 4 | _aInfusion Pumps |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aN-Methylaspartate _xadministration & dosage |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aValine _xadministration & dosage |
| 700 | 1 | _aFisher, M | |
| 700 | 1 | _aBaron, B M | |
| 700 | 1 | _aMetcalf, G | |
| 773 | 0 |
_tStroke _gvol. 25 _gno. 6 _gp. 1241-4; discussion 1245-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.25.6.1241 _zAvailable from publisher's website |
| 999 |
_c8202293 _d8202293 |
||